In line with the results obtained in MM with ATR inhibitors in combination with melphalan, AZD7762 has also been shown to potentiate the antiproliferative effects of bendamustine, melphalan, and doxorubicin in p53-deficient MM cell lines [106]. The gene discussed is TP53; the disease is Miyoshi myopathy.